Tvardi Therapeutics Inc (TVRD) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Tvardi Therapeutics Inc   (NASDAQ: TVRD)


Tvardi Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Tvardi Therapeutics Inc's ROI in the second quarter of 2026?
Tvardi Therapeutics Inc recorded a cumulative net loss of $-31 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -170.81%.

Within the Healthcare sector 184 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3781 to 3872.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 8 15 21 28 33
Return On Investment (TTM) -170.81 % -83.24 % -335.59 % 184.18 % 69.98 %
TVRD's Overall Ranking # 3872 # 3781 # 3392 # 3392 # 3409
Seq. Investment Change TTM -25.52 % 254.26 % - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -31 -20 -23 -19 -19

TVRD Company Profile >> Back to TVRD Roi Comparisons >> See Annual TVRD Return On Investment



Return On Investment TVRD's Ranking
Within: No.
Industry # 69
Sector # 185
Overall # 3872

Return On Investment Statistics
High Average Low
31.01 %
-56.46 %
-178.73 %
(Sep 30 2016)   (Dec 31 2015)







Financial Statements
Tvardi Therapeutics Inc's II. Quarter Investments $ 8 Millions TVRD's Balance sheet
Tvardi Therapeutics Inc's II. Quarter Income $ -6 Millions Quarterly TVRD's Income Statement
TVRD's Income by Division See TVRD's Income by Division


TVRD Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 21 40 100 159 229
Y / Y Investment Growth -47.23 % -60.25 % -36.86 % -30.8 % -9.2 %
Net Income in Millions -18 -71 -119 -85 -88
Y / Y Net Income Growth - - - - -
Annual Return On Investment -86.61 % -177.81 % -118.22 % -53.83 % -38.55 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TVRD's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TVRD's Competitors
Subscribers only: Roi for Tvardi Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for TVRD's Customers

Other Ratios
TVRD's Roa TVRD's Inventory Turnover Ratio TVRD's Growth Rates TVRD's Dividend Statistics
TVRD's Profitability Ratios TVRD's Asset Turnover Ratio TVRD's Dividend Growth
TVRD's Roe TVRD's Valuation Ratios TVRD's Financial Strength Ratios TVRD's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:08:32+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.